Bio-Gene Technology (ASX:BGT) Other Current Receivables: A$0.00 Mil (As of Dec. 2025)


What is Bio-Gene Technology Other Current Receivables?

Bio-Gene Technology ASX:BGT Other Current Receivables is A$0.00 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Bio-Gene Technology's Other Current Receivables for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Bio-Gene Technology's annual Other Current Receivables increased from Jun. 2023 (A$0.45 Mil) to Jun. 2024 (A$0.52 Mil) but then declined from Jun. 2024 (A$0.52 Mil) to Jun. 2025 (A$0.47 Mil).

Bio-Gene Technology Other Current Receivables Related Terms

Bio-Gene Technology Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Bio-Gene Technology's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Gene Technology Other Current Receivables Chart

Bio-Gene Technology Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Receivables
Get a 7-Day Free Trial 0.50 0.44 0.45 0.52 0.47

Bio-Gene Technology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.52 0.00 0.47 0.00

Bio-Gene Technology Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of A$0.00 Mil mean?
Bio-Gene Technology (ASX:BGT) has a Other Current Receivables of A$0.00 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Bio-Gene Technology and its competitors.
Is Bio-Gene Technology's Other Current Receivables too high?
Bio-Gene Technology's current Other Current Receivables is A$0.00 Mil.
How does Bio-Gene Technology's Other Current Receivables compare to VRTX and REGN?
Bio-Gene Technology's Other Current Receivables of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Bio-Gene Technology and its competitors. Bio-Gene Technology's current Other Current Receivables is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Gene Technology stock overvalued right now?
Bio-Gene Technology (ASX:BGT) has a current Other Current Receivables of A$0.00 Mil. The current Other Current Receivables is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Bio-Gene Technology (ASX:BGT), the current Other Current Receivables is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Gene Technology Business Description

Address 400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance and toxicity. Its products are based on a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. Bio-Gene's products have multiple applications across public health, crop protection, grain storage, and consumer use. The company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.